Skip Navigation

AIDSInfo logo

 
Home > Drugs > TNX-355

TNX-355
Drug Class: Entry and Fusion Inhibitors
TNX-355 is a type of medicine called an entry inhibitor. Entry inhibitors work by blocking HIV from entering human cells.


HIV/AIDS-Related Uses
TNX-355 is an investigational medicine that is not yet approved by the FDA for use outside of clinical trials. It is being studied for the treatment of HIV infection. This medicine does not cure or prevent HIV infection or AIDS and does not reduce the risk of passing the virus to other people.

Dosage Form/Administration
TNX-355 comes in a liquid form that is given by intravenous infusion into a vein. Many different dosages based on body weight are being studied in clinical trials.

Contraindications
Individuals should tell a doctor about any medical problems before taking this medicine.

Possible Side Effects
Along with its desired effects, TNX-355 may cause some unwanted effects. These side effects are not yet known. So far, TNX-355 has been well tolerated in limited human studies.

Drug and Food Interactions
A doctor should be notified of any other medications being taken, including prescription, nonprescription (over-the-counter), or herbal medications.

Clinical Trials
Click here to search ClinicalTrials.gov for trials that use TNX-355.

Manufacturer Information
TNX-355
  Tanox, Inc.
  10555 Stella Link
  Houston,  TX  77025
  (866) 312-5200
    
Updated August 8, 2008